NLM Digital Collections

Search

Start Over Subjects Prescription Drugs -- economics ✖Remove constraint Subjects: Prescription Drugs -- economics Subjects United States ✖Remove constraint Subjects: United States Genre Technical Report ✖Remove constraint Genre: Technical Report

3. Assessing user fees under the Prescription Drug User Fee Amendments of 2017

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, May 2018
Subject(s):
Fees and Charges
Investigational New Drug Application -- economics
Prescription Drugs -- economics
Biological Products -- economics
Orphan Drug Production -- economics
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

4. Status of U.S. health insurance coverage and the potential of recent congressional health reform bills to expand coverage and lower consumer costs: invited testimony : U.S. House of Representatives, Committee on Rules : hearing on "Medicare for All Act of 2019"

Author(s):
Collins, Sara R., author
Publication:
New York, NY : The Commonwealth Fund, April 30, 2019
Subject(s):
Insurance Coverage -- economics
Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- economics
Insurance, Health -- legislation & jurisprudence
Financing, Personal
Forecasting
Health Benefit Plans, Employee -- economics
Health Benefit Plans, Employee -- statistics & numerical data
Health Benefit Plans, Employee -- trends
Health Care Costs -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Income
Insurance Coverage -- trends
Insurance, Health -- trends
Insurance, Health, Reimbursement
Medically Uninsured -- statistics & numerical data
Prescription Drugs -- economics
Humans
United States
United States.

5. Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis

Author(s):
Anderson-Cook, Anna, author
Maeda, Jared, author
Nelson, Lyle, author
Publication:
[Washington, DC] : Congressional Budget Office, March 2019
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States

6. Prices for and spending on specialty drugs in Medicare Part D and Medicaid

Publication:
[Washington, DC] : Congressional Budget Office, March 2019
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States

7. Spending on shoppable services in health care

Author(s):
Frost, Amanda, author
Newman, David, author
Publication:
Washington, DC, : Health Care Cost Institute, March 2016
Subject(s):
Consumer Behavior
Health Care Costs -- statistics & numerical data
Health Expenditures -- statistics & numerical data
Arthroplasty, Replacement, Hip -- economics
Arthroplasty, Replacement, Knee -- economics
Deductibles and Coinsurance
Disclosure
Health Benefit Plans, Employee -- economics
Prescription Drugs -- economics
Humans
United States

8. Consumer-driven health plans: a cost and utilization analysis

Author(s):
Frost, Amanda, author
Kennedy, Kevin, author
Publication:
Washington, DC, : Health Care Cost Institute, September 2016
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Health Services -- utilization
Consumer Behavior
Adolescent
Adult
Child
Emergency Medical Services -- economics
Financing, Personal
Forecasting
Insurance, Health -- economics
Middle Aged
Prescription Drugs -- economics
Sex Factors
Humans
United States

9. Getting to the root of high prescription drug prices: drivers and potential solutions

Author(s):
Waxman, Henry, author
Corr, Bill, author
Martin, Kristi, author
Duong, Sophia, author
Publication:
[New York, N.Y.] : Commonwealth Fund, July 2017
Subject(s):
Cost Control
Drug Costs
Health Policy
Prescription Drugs -- economics
Drug Industry -- economics
Drugs, Generic -- economics
Economic Competition
Legislation, Drug
Orphan Drug Production -- economics
Humans
United States

10. Does Medicare Part D protect the elderly from financial risk?

Author(s):
Englehardt, Gary V., author
Gruber, Jonathan, author
Publication:
Chestnut Hill, MA : Center for Retirement Research at Boston College, June 2011
Subject(s):
Financing, Personal
Health Services for the Aged -- economics
Insurance Coverage -- economics
Medicare Part D -- economics
Risk Sharing, Financial
Aged
Drug Costs
Forecasting
Health Care Surveys
Health Expenditures -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Medicare Part D -- statistics & numerical data
Medicare Part D -- trends
Prescription Drugs -- economics
Socioeconomic Factors
Humans
United States